The CPPDD-associated ANKH M48T mutation interrupts the interaction of ANKH with the sodium/phosphate cotransporter PiT-1.

J Rheumatol

Toronto Western Research Institute, University Health Network, University of Toronto, and Toronto Western Hospital, Mc14-419, 399 Bathurst Street, Toronto, Ontario M5T 2S8, Canada.

Published: June 2009

Objective: Numerous dominant human homolog of progressive ankylosis (ANKH) mutations have been identified in familial calcium pyrophosphate dihydrate crystal deposition disease (CPPDD). Due to the dominant nature of these mutations, we investigated whether ANKH interacts with other proteins; and if so, whether any CPPDD-associated ANKH mutation might disrupt such protein interactions.

Methods: Stable ATDC5 ANKH wt- and ANKH M48T-transfectants were generated. Lysates from these transfectants were used to identify candidate protein interaction with ANKH by coimmunoprecipitation followed by Western blot analysis. The effect of high phosphate on the expression of genes involved in modulating Pi (inorganic phosphate)/PPi (inorganic pyrophosphate) homeostasis in these transfectants was assessed.

Results: We showed that ANKH protein associates with the sodium/phosphate cotransporter PiT-1, and that ANKH M48T mutant protein failed to interact with PiT-1. We also showed that upon high phosphate treatment, the normally coordinated upregulation of endogenous Ank and PiT1 transcript expression was disrupted in ANKH M48T transfectants.

Conclusion: Our results suggested that there is a coordinated interrelationship between 2 key participants of Pi and PPi metabolism, ANKH and PiT-1.

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.081118DOI Listing

Publication Analysis

Top Keywords

ankh m48t
12
ankh
11
cppdd-associated ankh
8
interaction ankh
8
sodium/phosphate cotransporter
8
cotransporter pit-1
8
high phosphate
8
m48t mutation
4
mutation interrupts
4
interrupts interaction
4

Similar Publications

The CPPDD-associated ANKH M48T mutation interrupts the interaction of ANKH with the sodium/phosphate cotransporter PiT-1.

J Rheumatol

June 2009

Toronto Western Research Institute, University Health Network, University of Toronto, and Toronto Western Hospital, Mc14-419, 399 Bathurst Street, Toronto, Ontario M5T 2S8, Canada.

Objective: Numerous dominant human homolog of progressive ankylosis (ANKH) mutations have been identified in familial calcium pyrophosphate dihydrate crystal deposition disease (CPPDD). Due to the dominant nature of these mutations, we investigated whether ANKH interacts with other proteins; and if so, whether any CPPDD-associated ANKH mutation might disrupt such protein interactions.

Methods: Stable ATDC5 ANKH wt- and ANKH M48T-transfectants were generated.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!